Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018

ABSTRACTHuman coronavirus NL63 (HCoV-NL63) is primarily associated with common cold in children, elderly and immunocompromised individuals. Outbreaks caused by HCoV-NL63 are rare. Here we report a cluster of HCoV-NL63 cases with severe lower respiratory tract infection that arose in Guangzhou, China...

Full description

Bibliographic Details
Main Authors: Yanqun Wang, Xin Li, Wenkuan Liu, Mian Gan, Lu Zhang, Jin Wang, Zhaoyong Zhang, Airu Zhu, Fang Li, Jing Sun, Guoxian Zhang, Zhen Zhuang, Jiaying Luo, Dehui Chen, Shuyan Qiu, Li Zhang, Duo Xu, Chris Ka Pun Mok, Fuchun Zhang, Jingxian Zhao, Rong Zhou, Jincun Zhao
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1717999
_version_ 1797265883985346560
author Yanqun Wang
Xin Li
Wenkuan Liu
Mian Gan
Lu Zhang
Jin Wang
Zhaoyong Zhang
Airu Zhu
Fang Li
Jing Sun
Guoxian Zhang
Zhen Zhuang
Jiaying Luo
Dehui Chen
Shuyan Qiu
Li Zhang
Duo Xu
Chris Ka Pun Mok
Fuchun Zhang
Jingxian Zhao
Rong Zhou
Jincun Zhao
author_facet Yanqun Wang
Xin Li
Wenkuan Liu
Mian Gan
Lu Zhang
Jin Wang
Zhaoyong Zhang
Airu Zhu
Fang Li
Jing Sun
Guoxian Zhang
Zhen Zhuang
Jiaying Luo
Dehui Chen
Shuyan Qiu
Li Zhang
Duo Xu
Chris Ka Pun Mok
Fuchun Zhang
Jingxian Zhao
Rong Zhou
Jincun Zhao
author_sort Yanqun Wang
collection DOAJ
description ABSTRACTHuman coronavirus NL63 (HCoV-NL63) is primarily associated with common cold in children, elderly and immunocompromised individuals. Outbreaks caused by HCoV-NL63 are rare. Here we report a cluster of HCoV-NL63 cases with severe lower respiratory tract infection that arose in Guangzhou, China, in 2018. Twenty-three hospitalized children were confirmed to be HCoV-NL63 positive, and most of whom were hospitalized with severe pneumonia or acute bronchitis. Whole genomes of HCoV-NL63 were obtained using next-generation sequencing. Phylogenetic and single amino acid polymorphism analyses showed that this outbreak was associated with two subgenotypes (C3 and B) of HCoV-NL63. Half of patients were identified to be related to a new subgenotype C3. One unique amino acid mutation at I507 L in spike protein receptor binding domain (RBD) was detected, which segregated this subgenotype C3 from other known subgenotypes. Pseudotyped virus bearing the I507 L mutation in RBD showed enhanced entry into host cells as compared to the prototype virus. This study proved that HCoV-NL63 was undergoing continuous mutation and has the potential to cause severe lower respiratory disease in humans.
first_indexed 2024-03-07T17:24:13Z
format Article
id doaj.art-9d852b9b012d4a8a87cd04d0e572a8db
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-04-25T00:51:53Z
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-9d852b9b012d4a8a87cd04d0e572a8db2024-03-11T16:04:24ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-019124625510.1080/22221751.2020.1717999Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018Yanqun Wang0Xin Li1Wenkuan Liu2Mian Gan3Lu Zhang4Jin Wang5Zhaoyong Zhang6Airu Zhu7Fang Li8Jing Sun9Guoxian Zhang10Zhen Zhuang11Jiaying Luo12Dehui Chen13Shuyan Qiu14Li Zhang15Duo Xu16Chris Ka Pun Mok17Fuchun Zhang18Jingxian Zhao19Rong Zhou20Jincun Zhao21State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaInstitute of Infectious disease, Guangzhou Eighth People's Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaInstitute of Infectious disease, Guangzhou Eighth People's Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaABSTRACTHuman coronavirus NL63 (HCoV-NL63) is primarily associated with common cold in children, elderly and immunocompromised individuals. Outbreaks caused by HCoV-NL63 are rare. Here we report a cluster of HCoV-NL63 cases with severe lower respiratory tract infection that arose in Guangzhou, China, in 2018. Twenty-three hospitalized children were confirmed to be HCoV-NL63 positive, and most of whom were hospitalized with severe pneumonia or acute bronchitis. Whole genomes of HCoV-NL63 were obtained using next-generation sequencing. Phylogenetic and single amino acid polymorphism analyses showed that this outbreak was associated with two subgenotypes (C3 and B) of HCoV-NL63. Half of patients were identified to be related to a new subgenotype C3. One unique amino acid mutation at I507 L in spike protein receptor binding domain (RBD) was detected, which segregated this subgenotype C3 from other known subgenotypes. Pseudotyped virus bearing the I507 L mutation in RBD showed enhanced entry into host cells as compared to the prototype virus. This study proved that HCoV-NL63 was undergoing continuous mutation and has the potential to cause severe lower respiratory disease in humans.https://www.tandfonline.com/doi/10.1080/22221751.2020.1717999human coronavirus NL63new subgenotypepneumoniawhole-genome sequencingphylogenetic analysisviral entry
spellingShingle Yanqun Wang
Xin Li
Wenkuan Liu
Mian Gan
Lu Zhang
Jin Wang
Zhaoyong Zhang
Airu Zhu
Fang Li
Jing Sun
Guoxian Zhang
Zhen Zhuang
Jiaying Luo
Dehui Chen
Shuyan Qiu
Li Zhang
Duo Xu
Chris Ka Pun Mok
Fuchun Zhang
Jingxian Zhao
Rong Zhou
Jincun Zhao
Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
Emerging Microbes and Infections
human coronavirus NL63
new subgenotype
pneumonia
whole-genome sequencing
phylogenetic analysis
viral entry
title Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
title_full Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
title_fullStr Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
title_full_unstemmed Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
title_short Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
title_sort discovery of a subgenotype of human coronavirus nl63 associated with severe lower respiratory tract infection in china 2018
topic human coronavirus NL63
new subgenotype
pneumonia
whole-genome sequencing
phylogenetic analysis
viral entry
url https://www.tandfonline.com/doi/10.1080/22221751.2020.1717999
work_keys_str_mv AT yanqunwang discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT xinli discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT wenkuanliu discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT miangan discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT luzhang discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT jinwang discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT zhaoyongzhang discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT airuzhu discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT fangli discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT jingsun discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT guoxianzhang discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT zhenzhuang discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT jiayingluo discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT dehuichen discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT shuyanqiu discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT lizhang discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT duoxu discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT chriskapunmok discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT fuchunzhang discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT jingxianzhao discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT rongzhou discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018
AT jincunzhao discoveryofasubgenotypeofhumancoronavirusnl63associatedwithseverelowerrespiratorytractinfectioninchina2018